Stock Fundamentals

Company Information

Company Name
Compass Therapeutics Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US20454B1044
CIK: 0001738021
CUSIP: 20454B104
Currency: USD
Full Time Employees: 39
Phone: 617 500 8099
Fiscal Year End: December
IPO Date: Apr 05, 2021
Description:

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig, is a bispecific antibody that targets delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A), which are critical to angiogenesis and tumor vascularization. It also develops CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137, a key co-stimulatory receptor on immune cells; CTX-8371, a bispecific inhibitor that targets programmed cell death protein-1 (PD-1) and ligand PD-L1 checkpoint inhibitor antibodies; and CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Address:

80 Guest Street, Boston, MA, United States, 02135

Directors & Officers

Name Title Year Born
Dr. Thomas J. Schuetz M.D., Ph.D. CEO & Vice Chairman 1961
Mr. Barry Shin J.D., M.B.A. Chief Financial Officer 1972
Mr. Jonathan E. Anderman J.D. Senior VP, General Counsel & Corporate Secretary 1983
Mr. Neil L. Lerner CPA Senior VP & Chief Accounting Officer 1967
Mr. Bing Gong Ph.D. Chief Scientific Officer 1976
Anna Gifford Senior Manager of Communications & Chief of Staff NA
Ms. Karin Herrera B.A. Senior VP & Head of Clinical Operations NA
Dr. James Kranz Ph.D. VP and Head of Chemistry Manufacturing & Controls NA
Dr. Cynthia A. Sirard M.D., Ph.D. Chief Medical Officer 1970
Mr. Arjun Prasad M.B.A., M.P.H. Chief Commercial Officer 1978

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 27, 2025 Thomas J Schuetz N/A Purchase 10.00K $2.11 $21.10K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
TANG CAPITAL MANAGEMENT LLC 16.79M Mar 31, 2026 9.32% $4.51 0.00%
Orbimed Advisors, LLC 15.22M Mar 31, 2026 8.45% $1.60 0.00%
Suvretta Capital Management, LLC 14.31M Mar 31, 2026 7.94% $1.93 0.88%
Vivo Capital, LLC 9.55M Mar 31, 2026 5.30% $4.20 0.00%
BlackRock Inc 9.51M Mar 31, 2026 5.28% $0.00 1.25%
Adage Capital Partners Gp LLC 8.49M Mar 31, 2026 4.71% $0.07 91.29%
Vanguard Group Inc 8.05M Dec 31, 2025 4.47% $0.00 13.95%
Enavate Sciences GP, LLC 7.79M Mar 31, 2026 4.32% $11.72 0.00%
Bvf Inc 7.76M Mar 31, 2026 4.31% $1.31 0.00%
State Street Corp 6.69M Mar 31, 2026 3.72% $0.00 36.90%
RTW INVESTMENTS, LLC 4.19M Mar 31, 2026 2.32% $0.22 67.46%
Deerfield Management Co 3.61M Mar 31, 2026 2.00% $0.23 0.00%
Geode Capital Management, LLC 3.57M Mar 31, 2026 1.98% $0.00 1.81%
Rock Springs Capital Management LP 3.31M Mar 31, 2026 1.84% $1.03 -15.84%
Logos Global Management LP 3.15M Mar 31, 2026 1.75% $0.83 173.91%
Blue Owl Capital Holdings LP 2.94M Mar 31, 2026 1.63% $4.18 -15.14%
Qube Research & Technologies 2.55M Mar 31, 2026 1.42% $0.02 477.26%
UBS Group AG 2.39M Mar 31, 2026 1.33% $0.00 1,324.63%
Sofinnova Ventures 2.06M Mar 31, 2026 1.14% $0.41 -38.90%
The Goldman Sachs Group Inc 2.00M Mar 31, 2026 1.11% $0.00 31.50%

Shares Statistics

Shares Outstanding: 180.09M
Shares Float: 122.69M
% Insiders: 1,245.50%
% Institutions: 9,407.40%
Short % Float: 20.59%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 4.19M 2.33% ▲ 0.00% Apr 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 4.01M 2.23% ▼ 0.72% Apr 30, 2026
3 iShares Russell 2000 ETF 3.04M 1.69% ▲ 0.85% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 1.72M 0.96% ▲ 0.52% Apr 30, 2026
5 Fidelity Small Cap Index 1.28M 0.71% ▲ 0.94% Feb 28, 2026
6 Russell 2000 Equity Index Fund B 822.95K 0.46% ▲ 36.29% Dec 31, 2025
7 Fidelity Extended Market Index 816.28K 0.45% ▲ 1.33% Mar 31, 2026
8 MEDICAL BioHealth EUR Acc 780.58K 0.43% ▼ 0.10% Mar 31, 2026
9 State St Russell Sm/Mid Cp® Indx SL Cl I 757.60K 0.42% ▲ 0.00% Apr 30, 2026
10 Vanguard Russell 2000 ETF 651.41K 0.36% ▲ 2.57% Apr 30, 2026

Valuation Metrics

Enterprise Value: $213.10M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $374.58M
EBITDA: $-75.02M
Book Value: $1.04
Earnings/Share: $-0.40
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -27.91%
ROE (TTM): -45.95%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 15.02x 0.01x 0.10x N/A -0.01x
2024-12-31 14.96x 0.00x 0.11x N/A -0.01x
2023-12-31 19.73x 0.01x 0.05x N/A -0.02x
2022-12-31 12.05x 0.01x 0.09x -17.65x -0.03x
2021-12-31 13.84x 0.01x 0.09x -221.30x -0.01x
2020-12-31 4.97x 0.23x 0.23x -30.63x -0.37x
2019-12-31 2.67x -0.13x 4.90x -27.73x -0.47x
2018-12-31 6.96x -0.17x 2.31x -49.95x -0.41x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CMPX.US!